| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a composition for treating or preventing erythema. <P>SOLUTION: The local composition contains a compound selected from the group consisting of (5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine (commonly referred to as brimonidine), oxymetazoline, epinephrine, and pharmaceutically acceptable salts thereof (e.g., brimonidine tartrate), or a combination thereof, as well as a pharmaceutically acceptable carrier. <P>COPYRIGHT: (C)2012,JPO&INPIT |
